Walgreens has been sued by Arkansas Attorney General Leslie Rutledge, and the case was filed earlier this week. In her filing, she claimed that the pharmacy chain company played a big part in making the opioid crisis situation in the state worse.
Rutledge accused Walgreens of rendering a large number of orders for painkillers, and most of them are suspicious. The lawyer said that this is a violation of Arkansas’ Deceptive Trade Practices Act.
The lawsuit against Walgreens
The lawsuit was filed in Pulaski County Court, and it was stated that the pharmacy did not do enough to make sure that the prescriptions are legitimate and not questionable. It was said that because of Walgreens' failure to monitor the orders, large amounts of the regulated drug were distributed in Arkansas, as per Arkansas Democrat Gazelle.
"Walgreens has a legal responsibility to report suspicious orders and suspicious prescriptions," the attorney general said. "By failing to do so they enabled the black market of prescription drugs to increase dramatically, thus leading to more, greater addiction and more lives lost in the state of Arkansas."
As stated in the lawsuit, from 2006 to 2014, Walgreens fulfilled orders of over 142 million dosages of oxycodone and hydrocodone in the state. Rutledge said that this big amount should have alerted the company to the fact that suspicious orders were being placed.
It was added that such quantities that were distributed in Arkansas far exceeded the normal amount that could be consumed for medical legit purposes. “Walgreens failed to report and halt those orders and instead increased the number of pills distributed,” the statement from the suit reads.
With the filing, the state is seeking a directive that will force Walgreens to act responsibly and comply with federal and state laws. It is also seeking appropriate civil penalties for every violation that the company may have committed against the state’s consumer protection laws.
Walgreens denies the allegations
Walgreens refuted the accusations and stated that it never produced or marketed opioids. The company’s spokesperson further told FOX Business that they never sold the said drug to pain clinics, online pharmacies, and 'pill mills' that worsened the opioid crisis.
"Prior to 2014, we delivered opioids only to our own pharmacies, and the only place we ever sold FDA-approved opioid medications was at the pharmacy counter when presented with valid prescriptions written by DEA-licensed physicians for legitimate medical needs," the firm’s spokesperson said.
Finally, he added that the company’s pharmacists always evaluate and take the law into consideration before deciding whether to fill a prescription for controlled substances.


Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates
Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets
Proxy Advisors Urge Vote Against ANZ’s Executive Pay Report Amid Scandal Fallout
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends
Magnum Audit Flags Governance Issues at Ben & Jerry’s Foundation Ahead of Spin-Off
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 



